ubmslatePT-logo-ubm

PT Mobile Logo

Search form

Topics:

Mark L. Fuerst

Mark L. Fuerst

Mark L. Fuerst is a freelance health and medical writer for ConsultantLive, Rheumatology Network, Psychiatric Times, and other UBM publications. He writes about rheumatology, psychiatry, neurology, endocrinology, oncology, and men’s health.

Posts by Author

Researchers investigate Alzheimer disease in 3 key areas: sleep, seizures, and proton pump inhibitors.

Study authors propose a new asthma patient “phenotype” in which a previous severe event is the sole predictor of another one.

Results of a recent study into the role of lipids in atopic asthma could help identify new targets for therapy.

New research suggests it’s possible to reverse the metabolic impact of childhood obesity and avert T2DM in adulthood.

Among the clues revealed in 3 recent studies: brain amyloid, saliva biomarkers, and microvascular dysfunction.

Find research on diabetes patients that could shift your thinking on home blood glucose monitoring; metformin efficacy in T1DM; and race and A1c.

Clinicians need to track not only current alcohol consumption among their HIV-infected patients—but also past use.

Three new studies show exercise can improve cognitive function, psychotropics for PTSD may raise dementia risk, and 3 biomarkers can help predict cognitive decline in elderly persons.

The latest news in geriatric psychiatry covers olfactory deficits in cognitively impaired patients, a smartphone app for older adults with serious mental illness, and adjunctive ketamine for late-life depression.

©Sean K/Shutterstock.com

Antiretroviral therapy has dramatically reduced AIDS-associated morbidity and mortality -- but only in those who know they are HIV positive and if they maintain sustained engagement with care.

Pages

By clicking Accept, you agree to become a member of the UBM Medica Community.